Albert S. DeNittis

Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial

Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé et al. · Journal of Clinical Oncology · 2014 · 1.1K citations · Full text

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Prediction of Survival by [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer Undergoing Definitive Chemoradiation Therapy: Results of the ACRIN 6668/RTOG 0235 Trial

Mitchell Machtay, Fenghai Duan, Barry A. Siegel et al. · Journal of Clinical Oncology · 2013 · 172 citations · Full text

NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer

Theodore S. Hong, Jennifer Moughan, Michael Garofalo et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 116 citations · Full text

Radiation Therapy, Medicine, Radionuclide Therapy +6

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

Ethan Basch, Stephanie L. Pugh, Amylou C. Dueck et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 115 citations · Full text

Adverse Events, Oncology, Adverse Event +10